1
|
Habibi M, Golmakani MT, Eskandari MH, Hosseini SMH. Potential prebiotic and antibacterial activities of fucoidan from Laminaria japonica. Int J Biol Macromol 2024; 268:131776. [PMID: 38657938 DOI: 10.1016/j.ijbiomac.2024.131776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 04/05/2024] [Accepted: 04/21/2024] [Indexed: 04/26/2024]
Abstract
Fucoidan from Laminaria japonica became sterilized with an autoclave and ultraviolet (UV) radiation. Potential prebiotic and antibacterial activities of sterilized fucoidans (SF) were the subject of investigation. Molecular weight, monosaccharide composition, FTIR, and NMR spectra of SF underwent evaluations to elucidate the relationship between the structure and activities of SF. The growth of Lactobacillus rhamnosus GG and L. acidophilus with autoclave sterilized fucoidan (ASF) and the growth of L. plantarum, L. gasseri, L. paracasei, and L. reuteri with UV sterilized fucoidan (USF) increased significantly. Also, fucoidan was vastly more effective than fructooligosaccharides in improving the growth of L. gasseri, L. reuteri, and L. paracasei. The growth of Escherichia coli and Bacillus cereus decreased at each SF concentration. ASF was more effective against E. coli, B. cereus, and Staphylococcus aureus than the USF efficiency. However, USF exhibited more inhibitory effects on the growth of Enterobacteriaceae compared to the ASF efficiency. When comparing the ASF and USF, autoclave caused a considerable decrease in molecular weight and uronic acid content, increased fucose and galactose, and made no significant changes in NMR spectra. Fucoidan effectively promoted probiotic bacterial growth and reduced pathogenic outbreaks in the medium. Therefore, it can occur as a new algal prebiotic and antibacterial agent.
Collapse
Affiliation(s)
- Maryam Habibi
- Department of Food Science and Technology, School of Agriculture, Shiraz University, Shiraz, Iran
| | - Mohammad-Taghi Golmakani
- Department of Food Science and Technology, School of Agriculture, Shiraz University, Shiraz, Iran..
| | - Mohammad Hadi Eskandari
- Department of Food Science and Technology, School of Agriculture, Shiraz University, Shiraz, Iran..
| | | |
Collapse
|
2
|
Yu H, Habibi M, Motamedi K, Semirumi DT, Ghorbani A. Utilizing stem cells in reconstructive treatments for sports injuries: An innovative approach. Tissue Cell 2023; 83:102152. [PMID: 37451009 DOI: 10.1016/j.tice.2023.102152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Revised: 06/17/2023] [Accepted: 06/29/2023] [Indexed: 07/18/2023]
Abstract
Orthopedic tissue engineering is a rapidly evolving field that holds great promise for the reconstruction and natural repair of bone and joint tissues. Bone loss, fractures, and joint degeneration are common problems that can result from a variety of pathological conditions, and their restoration and replacement are essential not only for functional purposes but also for improving the quality of life for patients. However, current methods rely heavily on artificial materials that can potentially lead to further tissue damage, making tissue engineering a highly attractive alternative. This innovative approach involves the utilization of stem cells (SCs), which are seeded onto a scaffold to form a biological complex. Among these SCs, mesenchymal stem cells (MSCs) extracted from bone marrow and adipose tissue have shown immense potential for bone and joint tissue regeneration. The success of orthopedic tissue engineering is contingent on the careful selection of appropriate scaffolds and inducing molecules, which play a critical role in carrying and supporting cells and inducing their differentiation. This review article comprehensively analyzes the three vital aspects of orthopedic tissue engineering - SCs, scaffolds, and inducing molecules - in order to provide a deeper understanding of this emerging field and its potential for the future of orthopedic medicine.
Collapse
Affiliation(s)
- Hongying Yu
- Physical Education Department, Jingchu University of Technology, Jingmen 448000, Hubei, China.
| | - M Habibi
- Faculty of Architecture and Urbanism, UTE University, Calle Rumipamba S/N and Bourgeois, Quito, Ecuador; Department of Biomaterials, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai 600 077, India; Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam
| | - K Motamedi
- Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
| | - D T Semirumi
- Department of Biomaterials, Islamic Azad University, Isfahan, Iran.
| | - A Ghorbani
- Biotechnology Department, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
| |
Collapse
|
3
|
Galehdar N, Habibi M, Ebrahimzadeh F, Moradi B. Evaluation of the clinical educational environment based on the DREEM model from the viewpoint of the OR students. J Educ Health Promot 2023; 12:221. [PMID: 37546016 PMCID: PMC10402815 DOI: 10.4103/jehp.jehp_1861_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 02/21/2023] [Indexed: 08/08/2023]
Abstract
BACKGROUND The most important part of learning happens in the clinic. To determine the differences between the real educational environment and the desirable environment, the DREEM1 model is used. The present study was conducted to evaluate the clinical educational environment based on the DREEM model from the viewpoint of the OR2 students of the Lorestan University of Medical Sciences. MATERIALS AND METHODS The present descriptive-analytical cross-sectional study evaluated the viewpoint of 118 students of operation room (OR) technology using the DREEM (Dundee Ready Educational Environment Measure) questionnaire in the hospitals affiliated with the Lorestan University of Medical Sciences during the second semester of 2020. The DREEM questionnaire has 50 statements and is divided into five sections, which are rated on a five-point Likert scale (0-4). The data were analyzed using frequency distribution tables, mean and standard deviation indices, Mann-Whitney and Kruskal-Wallis tests. Data analysis was conducted using IBM SPSS Statistics 22.0. IBM Corp.; 2013. and the level of significance was set at 0.05. RESULTS The total perception of the students of the clinical educational environment was good and excellent in 73.8% of the cases and of the subscales was also good (50.8%-63.2%). There was a significant relation between the total score of students' perception of the clinical educational environment and age (Z = 5.618, P < 0.001), semester (χ2= 43.929, df = 3, P < 0.001), internship hospital (χ2= 12.948, df = 6, P = 0.044) and also the mean score of the subscales (P < 0.001). As the GPA3 and interest in the major increased, the mean score of total perception and its subscales also increased except for perception from the educators (P < 0.05). CONCLUSION According to the results, the studied students had a positive perception of the clinical educational environment. It is recommended that the scientific foundation of the educators, the physical facilities of the operating rooms, and social communication should be strengthened to improve the care, treatment, and educational services. It will be useful to use the results to improve the accreditation level of medical centers.
Collapse
Affiliation(s)
- Nasrin Galehdar
- Department of Surgical Technologist, Social Determinants of Health Research Center, School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Maryam Habibi
- PhD Student in Department of Anatomical Sciences, School of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Farzad Ebrahimzadeh
- Department of Biostatistics and Epidemiology, Nutritional Health Research Center, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Behzad Moradi
- PhD Candidate in Nursing, Student Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences,Tehran, Iran
| |
Collapse
|
4
|
Sharafi-Badr P, Ehsandoost E, Ghasemiyanpour N, Mohammadi M, Safari R, Habibi M. Effect of sodium alginate-calcium chloride coating and glycerol and sorbitol concentration on oxidative stability and fungal growth of Persian walnut (Juglans regia L.). RMIQ 2022. [DOI: 10.24275/rmiq/alim2928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
5
|
Milstein N, Saberito M, Bhatt A, Habibi M, Sichrovsky T, Preminger M, Shaw R, Mittal S, Musat D. Absence of atrial fibrillation in the blanking period following cryoballoon pulmonary vein isolation – does it always portend a good prognosis? Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cryoballoon (CB) pulmonary vein isolation (PVI) is an accepted method for ablation in patients with paroxysmal and persistent atrial fibrillation (PAF, PeAF). Freedom from AF in the blanking period (BP), conventionally defined as the first 3-months post-PVI, has been associated with the best long-term outcomes. However, the influence of antiarrhythmic drugs (AADs) during the BP on long-term outcomes is not well understood.
Objective
To compare long-term outcomes between patients who were and were not on an AAD prior to ablation and remained free from AF during the 3-month BP post CB PVI.
Methods
We enrolled consecutive AF patients undergoing CB PVI; all pts had an implantable loop recorder (ILR). No patient had any AF in the first 90 days post CB PVI. We divided the patients into three groups: (1) never had exposure to an AAD; (2) were intolerant to/failed AAD and thus were not taking an AAD at time of ablation; and (3) were on AAD at time of ablation. In the latter group, every effort was made to stop the AAD before the end of the BP.
Results
The cohort included 96 pts (66±10 years; 60 [63%] male; 55 [57%] PAF; CHA2DS2-VASc 2.5±1.4). There were 23 (24%) patients in group 1, 13 (14%) patients in group 2, and 60 (63%) pts in group 3. Patients in group 3 were more likely to have PeAF; AADs were stopped at a median of 36 days IQR (27, 91) in this group. Patients were followed for 1-year during which time 28 (29%) patients had recurrent AF (despite having no AF during the BP). The best outcome was seen in patients who never used an AAD; the worst outcome was seen in patients who were on an AAD at time of ablation (Figure 1).
Conclusion
Our data show that absence of AF during a 3-month post CB PVI BP alone does not guarantee good-long term outcome, unless the patient was never treated with an AAD. In contrast, in patients ablated while taking an AAD, recurrent AF was observed in 37% even though they were completely AF-free during the BP.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- N Milstein
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Saberito
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - A Bhatt
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Habibi
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - T Sichrovsky
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Preminger
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - R Shaw
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - S Mittal
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - D Musat
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| |
Collapse
|
6
|
Milstein N, Saberito M, Bhatt A, Habibi M, Sichrovsky T, Preminger M, Shaw R, Mittal S, Musat D. Recurrence of atrial fibrillation following pulmonary vein isolation: impact of body mass index on one- and three-year outcomes. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cryoballoon (CB) pulmonary vein isolation (PVI) is an accepted method for ablation in patients with paroxysmal and persistent atrial fibrillation (PAF, PeAF). However, there are a paucity of data about the impact of body mass index (BMI) on one-year and longer-term outcomes following ablation.
Objective
To objectively understand the impact of BMI on outcomes following CB PVI.
Methods
We enrolled consecutive AF patients undergoing CB PVI; all patients had an implantable loop recorder (ILR), which transmitted data wirelessly daily. We assessed AF recurrences after excluding an initial 3-month post-ablation blanking period.
Results
The cohort included 222 pts (66±9 years; 143 [64%] male; 120 [54%] PAF; CHA2DS2-VASc 2.6±1.6). The mean BMI was 30±5. Patients were followed for 763±347 days, during which time 50% and 68% had recurrent AF 1- and 3-years post ablation. We divided the cohort based on the mean BMI into 2 groups: BMI <30 and BMI >30. Heavier patients were younger and more likely to have PeAF. Over 1-year of follow-up, patients with a BMI <30 had similar likelihood of being free of AF to patients with a BMI >30 (46% vs, 56%, p=0.0.097, Figure 1, left). However, as patients were followed for 3-years, freedom from AF was significantly higher in patients with a BMI <30 (59% vs. 81% in BMI >30, p=0.002, Figure 1, right).
Conclusions
Our data show that although patients had similar outcomes 1-year post-ablation, during longer-term follow-up patients with a BMI >30 had a much worse outcome. Our study uniquely offers objective (using an ILR) assessment of the impact of BMI on long-term outcomes following CB PVI (homogenous ablation strategy). These data highlight the need to identify strategies to improve outcomes in obese patients.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- N Milstein
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Saberito
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - A Bhatt
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Habibi
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - T Sichrovsky
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - M Preminger
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - R Shaw
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - S Mittal
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| | - D Musat
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation , Ridgewood , United States of America
| |
Collapse
|
7
|
Habibi M, Sadeghi M, Arman A, Sobola D, Luna C, Mirzaei S, Zelati A, da Fonseca Filho HD, Ţălu Ş. Corrosion resistance and surface microstructure of Mg 3 N 2 /SS thin films by plasma focus instrument. Microsc Res Tech 2022; 85:2880-2893. [PMID: 35488428 DOI: 10.1002/jemt.24138] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Revised: 03/24/2022] [Accepted: 04/17/2022] [Indexed: 02/05/2023]
Abstract
Utilizing a plasma focus (PF) instrument, magnesium nitride (Mg3 N2 ) thin films were synthesized on stainless steel substrates. Twenty five optimum focus shots at 8 cm distance from the anode tip were used to deposit the films at different angular positions regarded to the anode axis. Scanning electron microscopy (SEM), atomic force microscopy (AFM), and X-ray diffraction (XRD) analyses were performed to assess the surface morphology and structural characteristics of Mg3 N2 films. Based on AFM images, these films were studied to understand the effect of angular position variation on their surfaces through morphological and fractal parameters. By increasing the angle, we verify that the grain size decreased from 130(0) nm to 75(5) nm and also the mean quadratic surface roughness of the films reduced in its average values from (28.97 ± 3.24) nm to (23.10 ± 1.34) nm. Power spectrum density analysis indicated that films become more self-affine at larger angles. Furthermore, the corrosion behavior of the films was investigated through a potentiodynamic polarization test in H2 SO4 solution. It was found that the ion energy and flux, varying with the angular positions from the anode tip, directly affected the nanostructured roughness and surface morphology of the samples. The electrochemical studies of films show that the uncoated sample presented the lowest corrosion resistance. The highest corrosion resistance was obtained for the sample deposited with 25 optimum shots and at 0° angular position reaching a reduction in the corrosion current density of almost 800 times compared to the pure stainless steel-304 substrate. HIGHLIGHTS: Mg3 N2 /SS films have been deposited at different angles by plasma focus (PF) instruments. The effect of angular position on the surface microtexture, morphological parameters, and corrosion features of the films was studied. The RBS measurement and X-ray diffraction are utilized to identify the crystalline phases and thickness of films.
Collapse
Affiliation(s)
- Maryam Habibi
- Plasma Physics Research Center, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Mohammad Sadeghi
- Mälardalen University, Mälardalens Högskola (EST), Vasteras, Sweden
| | - Ali Arman
- ACECR, Vacuum Technology Research Group, Sharif University Branch, Tehran, Iran
| | - Dinara Sobola
- Faculty of Electrical Engineering and Communication, Department of Physics, Brno University of Technology, Brno, Czech Republic
- Department of Inorganic Chemistry and Chemical Ecology, Dagestan State University, Makhachkala, Russia
| | - Carlos Luna
- Facultad de Ciencias Físico Matemáticas (FCFM), Universidad Autónoma de Nuevo León (UANL), San Nicolás de los Garza, Mexico
| | - Saeed Mirzaei
- CEITEC BUT, Brno University of Technology, Brno, Czech Republic
| | - Amir Zelati
- Department of Basic Sciences, Birjand University of Technology, Birjand, Iran
| | | | - Ştefan Ţălu
- The Directorate of Research, Development and Innovation Management (DMCDI), Technical University of Cluj-Napoca, Cluj-Napoca, Romania
| |
Collapse
|
8
|
Musat D, Milstein N, Saberito M, Bhatt A, Habibi M, Preminger M, Sichrovsky T, Shaw R, Mittal S. The impact of atrial fibrillation burden early post cryoballoon pulmonary vein isolation on long-term freedom from recurrent atrial fibrillation. Europace 2022. [DOI: 10.1093/europace/euac053.245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. A three-month blanking period (BP) is commonly used in clinical trials and practice. Early recurrence of AF portends worse ablation long-term outcome; however, the utility of using AF burden (AFB) early post cryoballoon (CB) PVI to predict long-term outcome is unknown.
Purpose
To determine, using ECG data acquired by an implantable loop recorder (ILR), the relationship between post-ablation AFB and long-term freedom from AF.
Methods
We enrolled consecutive patients with AF who had CB PVI and an ILR. We determined the monthly AFB for the first 3 months post CB PVI and assessed the relationship between AFB and 1-year freedom from AF. We defined 4 distinct AFB groups: (1) 0%, (2) > 0-0.1%, (3) > 0.1-0.5%, and (4) > 0.5%.
Results
There were 210 patients (66 ± 9 years; 138 [66%] male; 116 [55%] paroxysmal AF; CHA2DS2-VASc 2.5 ± 1.6). Following a 3-month BP, 101 (48%) patients had a recurrence of AF at 160 ± 86 days post-ablation. An AFB of > 0% over the first 3 months predicted AF recurrence (p < 0.0001, Figure 1). Patients with > 0.5% AF burden after 1st month and any AF after 2nd month post CB PVI have a very high long-term AF recurrence rate (Figure 2).
Conclusion
The best long term outcome post CB PVI is seen in pts who have no AF in the first 3 months post ablation. An AFB >0.5% after the first month and any AF after the second month portend ablation failure. These data define a clinical utility of using AFB to risk stratify patients post CB PVI.
Collapse
Affiliation(s)
- D Musat
- Valley Health System, Ridgewood, United States of America
| | - N Milstein
- Valley Health System, Ridgewood, United States of America
| | - M Saberito
- Valley Health System, Ridgewood, United States of America
| | - A Bhatt
- Valley Health System, Ridgewood, United States of America
| | - M Habibi
- Valley Health System, Ridgewood, United States of America
| | - M Preminger
- Valley Health System, Ridgewood, United States of America
| | - T Sichrovsky
- Valley Health System, Ridgewood, United States of America
| | - R Shaw
- Valley Health System, Ridgewood, United States of America
| | - S Mittal
- Valley Health System, Ridgewood, United States of America
| |
Collapse
|
9
|
Musat D, Milstein N, Saberito M, Bhatt A, Habibi M, Preminger M, Sichrovsky T, Shaw R, Mittal S. Yearly incidence and pattern of very late recurrence of atrial fibrillation as detected by continuous electrocardiographic monitoring using an implantable loop recorder. Europace 2022. [DOI: 10.1093/europace/euac053.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
A very late recurrence (VLR) of atrial fibrillation (AF) is considered present when patients have their first recurrence of AF > 12 months post-ablation. Little is known about the yearly rates and patterns of VLR AF recurrence.
Objective
To assess the yearly incidence and pattern of VLR in pts with AF who underwent cryoballoon (CB) pulmonary vein isolation (PVI).
Methods
We prospectively enrolled consecutive patients with AF who underwent CB PVI and had an implantable loop recorder (ILR) inserted up to 3 months post-ablation. Patients were followed for recurrent AF (excluding a 3-month post-ablation blanking period).
Results
Our cohort included 222 patients (66 ± 9 years; 143 [64%] male; 120 [54%] paroxysmal AF; CHA2DS2-VASc 2.6 ± 1.6). At 1-year, 111 (50%) patients remained free of AF. Two-year follow-up was available in 95 of these patients; 62 (65%) remained in sinus. Three-year follow-up was available in 42 of these patients; 36 (86%) remained in sinus (Figure). Of the 39 patients who developed AF after initially being free of AF for at least 1-year post ablation, 24 (62%) patients had either a frequent or persistent pattern of AF.
Conclusions
Our data show that the greatest likelihood of failure following a CB PVI occurs in the first year of ablation. The rate of failure becomes lower year by year. These data suggest that long term outcome may be driven more by the initial ablation as opposed to progressive evolution of the patient’s substrate
Collapse
Affiliation(s)
- D Musat
- Valley Health System, Ridgewood, United States of America
| | - N Milstein
- Valley Health System, Ridgewood, United States of America
| | - M Saberito
- Valley Health System, Ridgewood, United States of America
| | - A Bhatt
- Valley Health System, Ridgewood, United States of America
| | - M Habibi
- Valley Health System, Ridgewood, United States of America
| | - M Preminger
- Valley Health System, Ridgewood, United States of America
| | - T Sichrovsky
- Valley Health System, Ridgewood, United States of America
| | - R Shaw
- Valley Health System, Ridgewood, United States of America
| | - S Mittal
- Valley Health System, Ridgewood, United States of America
| |
Collapse
|
10
|
Musat D, Milstein N, Saberito M, Bhatt A, Habibi M, Preminger M, Sichrovsky T, Shaw R, Mittal S. Is there clinical utility to replacement of an implantable loop recorder in patients who have previously undergone cryoballoon pulmonary vein isolation? Europace 2022. [DOI: 10.1093/europace/euac053.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Implantable loop recorders (ILRs) are used for long-term ECG monitoring following catheter ablation in patients (pts) with atrial fibrillation (AF) to guide clinical management. However, little is known about what do when the ILR reaches end of service (EOS).
Purpose
To identify pts who underwent replacement of their ILR and determine the diagnostic yield and clinical utility of the replacement device.
Methods
We enrolled 222 consecutive pts with AF who underwent cryoballoon pulmonary vein isolation (CB PVI) and had an ILR. We identified pts who subsequently underwent ILR replacement. The diagnostic and clinical utility of the newly replaced ILR was determined.
Results
The cohort included 56 pts (64 + 9 years; 35 [63%] male; 27 [48%] PAF; CHA2DS2-VASc 2.3 ± 1.5) in whom the initial ILR reached EOS. They were followed for 3.7 ± 2.1 years. Recurrent AF was observed in 41 (73%) of these pts; this triggered an intervention in 17 (41%) pts (Figure). Of the other 15 (27%) pts without any documented AF, anticoagulation was withheld in 13 [87%] pts. Following ILR replacement, 33 (80%) of the 41 pts had more AF (n=11 [33%] required an intervention) and 5 additional pts had AF for the first time.
Conclusions
Our data show that after CB PVI, ILRs help guide decisions regarding rhythm management and oral anticoagulation. When the initial ILR was replaced by a second ILR, AF was detected (often for the first time) in some patients; the findings were used to guide clinical decision making in the entire cohort. Thus, at this time, it remains undefined when ECG monitoring of these pts can be stopped because it is no longer clinical meaningful.
Collapse
Affiliation(s)
- D Musat
- Valley Health System, Ridgewood, United States of America
| | - N Milstein
- Valley Health System, Ridgewood, United States of America
| | - M Saberito
- Valley Health System, Ridgewood, United States of America
| | - A Bhatt
- Valley Health System, Ridgewood, United States of America
| | - M Habibi
- Valley Health System, Ridgewood, United States of America
| | - M Preminger
- Valley Health System, Ridgewood, United States of America
| | - T Sichrovsky
- Valley Health System, Ridgewood, United States of America
| | - R Shaw
- Valley Health System, Ridgewood, United States of America
| | - S Mittal
- Valley Health System, Ridgewood, United States of America
| |
Collapse
|
11
|
Milstein N, Saberito M, Bhatt A, Habibi M, Sichrovsky T, Preminger M, Shaw R, Mittal S, Musat D. Defining the optimal blanking period duration after cryoballoon pulmonary vein isolation in patients with atrial fibrillation who have never been treated with an antiarrhythmic drug. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cryoballoon (CB) pulmonary vein isolation (PVI) is an approved method for ablation in patients with paroxysmal (PAF) or persistent (PeAF) atrial fibrillation (AF). Although the first 90 days post-ablation are considered within the blanking period (BP), the optimal duration of the BP remains undefined.
Purpose
To objectively define the BP duration in pts undergoing CB PVI by evaluating a cohort never treated with an antiarrhythmic drug (AAD).
Methods
We enrolled consecutive pts with either PAF or PeAF who underwent initial CB PVI; all pts had an implantable loop recorder (ILR) for long-term ECG monitoring. No pt received an AAD either before or after ablation. We determined the time to last AF episode within the first 90 days of ablation. We then correlated this to the likelihood a patient had recurrent AF between 91 and 365 days of ablation.
Results
There were 45 pts (67±8 years; 26 [58%] male; 40 [89%] PAF; CHA2DS2-VASc 2.6±1.3). We defined 4 distinct groups post ablation based on whether or not they had AF in the BP: (1) no AF days 0–90 (n=19 [42%]), (2) last AF days 0–30 (n=11 [24%]), (3) last AF days 31–60 (n=3 [7%]), and (4) last AF days 61–90 (n=12 [27%]). After the 90-day BP, 15 (33%) pts had AF recurrence. Pts with no AF and those with AF only within 30 days of ablation had similar long-term outcome; however, recurrent AF more than 32 days after ablation predicted long-term ablation failure (Figure).
Conclusion
The post CB PVI blanking period is just a month. AF recurrences beyond a month in patients not on an AAD are associated with AF recurrence in the majority of pts.
Funding Acknowledgement
Type of funding sources: None. Blanking Group by AF Recurrence
Collapse
Affiliation(s)
- N Milstein
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - M Saberito
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - A Bhatt
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - M Habibi
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - T Sichrovsky
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - M Preminger
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - R Shaw
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - S Mittal
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| | - D Musat
- The Valley Hospital, The Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, United States of America
| |
Collapse
|
12
|
Weber L, Sänger M, Münchmeyer J, Habibi M, Leser U, Akbik A. HunFlair: an easy-to-use tool for state-of-the-art biomedical named entity recognition. Bioinformatics 2021; 37:2792-2794. [PMID: 33508086 PMCID: PMC8428609 DOI: 10.1093/bioinformatics/btab042] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 01/13/2021] [Accepted: 01/20/2021] [Indexed: 01/31/2023] Open
Abstract
SUMMARY Named entity recognition (NER) is an important step in biomedical information extraction pipelines. Tools for NER should be easy to use, cover multiple entity types, be highly accurate and be robust toward variations in text genre and style. We present HunFlair, a NER tagger fulfilling these requirements. HunFlair is integrated into the widely used NLP framework Flair, recognizes five biomedical entity types, reaches or overcomes state-of-the-art performance on a wide set of evaluation corpora, and is trained in a cross-corpus setting to avoid corpus-specific bias. Technically, it uses a character-level language model pretrained on roughly 24 million biomedical abstracts and three million full texts. It outperforms other off-the-shelf biomedical NER tools with an average gain of 7.26 pp over the next best tool in a cross-corpus setting and achieves on-par results with state-of-the-art research prototypes in in-corpus experiments. HunFlair can be installed with a single command and is applied with only four lines of code. Furthermore, it is accompanied by harmonized versions of 23 biomedical NER corpora. AVAILABILITY AND IMPLEMENTATION HunFlair ist freely available through the Flair NLP framework (https://github.com/flairNLP/flair) under an MIT license and is compatible with all major operating systems. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.
Collapse
Affiliation(s)
- Leon Weber
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
- Group Mathematical Modelling of Cellular Processes, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany
| | - Mario Sänger
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
| | - Jannes Münchmeyer
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
- Section Seismology, GFZ German Research Centre for Geosciences, Potsdam 14473, Germany
| | - Maryam Habibi
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
| | - Ulf Leser
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
| | - Alan Akbik
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin 10099, Germany
| |
Collapse
|
13
|
Habibi M, Chehelcheraghi F. Effect of Bone Marrow Mesenchymal Stem Cell Sheets on Skin Capillary Parameters in a diabetic wound model: A Novel Preliminary Study. Iran Biomed J 2021; 25:334-42. [PMID: 34481425 PMCID: PMC8487679 DOI: 10.52547/ibj.25.5.334] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 01/18/2021] [Indexed: 01/04/2023]
Abstract
Background Treatment with BMMSCs has anti-inflammatory, tissue regenerative, angiogenic, and immune-stimulating effects. When using as sheets or accumulate, BMMSCs causes the development of neoangiogenesis in damaged skin tissue. Diabetes, a metabolic disorder, can negatively affect many physiological functions, including the process of skin injury repair. This adverse impact may increase the risk of skin surgery. RSF is commonly used in reconstructive surgery. The terminal part of the RSF is often affected by necrosis because of impaired blood flow, which is exacerbated in diabetes. This study investigated the effect of stem cells, applied as accumulated or cell sheets, along with RSF surgery on skin capillaries in STZ-induced diabetic rats. Methods Thirty male Wistar rats were divided into three groups (n = 10): diabetes-RSF control, diabetes-RSF local applied stem cells (loc-BMMSCs), diabetes-RSF applied stem cells as accumulated or cell sheets (ac-BMMSCs). Two weeks after the STZ injection, RSF surgery and stem cell therapy (6 × 109) were carried out (day zero). Furthermore, stereological methods were used to investigate the capillary patterns among the groups. Anti-CD31/PCAM1 immunohistochemistry was also used for further confirmation of changes in capillary parameters. Results The results demonstrated that capillaries were protected by MSC sheets in the flap tissue, and the thickness of the epidermal layer was improved, indicationg the possible beneficial effects of MSC sheets on diabetic wound treatment. Conclusion Stem cells, as ac-BMMSCs, may decrease the levels of wound healing complications in diabetes and can be considered as a cell therapy option in such conditions.
Collapse
Affiliation(s)
- Maryam Habibi
- Student Research Committee, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
| | - Farzaneh Chehelcheraghi
- Department of Anatomical Sciences, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
| |
Collapse
|
14
|
Musat D, Milstein NS, Saberito M, Bhatt A, Habibi M, Sichrovsky T, Preminger MW, Shaw RE, Mittal S. Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs? Europace 2021. [DOI: 10.1093/europace/euab116.254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Cryoballoon pulmonary vein isolation (CB) is an accepted method for ablation in patients with atrial fibrillation (AF). A three-month blanking period (BP) is commonly used in clinical trials and practice. However, when the optimal BP duration differs in patients (pts) on or off an antiarrhythmic drug (AAD) at time of ablation remains undefined.
Objective
To compare the BP duration in pts undergoing CB while either taking or not taking an AAD.
Methods
We enrolled consecutive pts with AF who had CB PVI while on an AAD. All pts had an implantable loop recorder (ILR). We prospectively followed all pts and determined the time to last AF episode during the 90-day post-PVI BP. This was then correlated with likelihood of having an AF recurrence between 3-12 months post-PVI.
Results
The cohort included 164 pts (66 ± 9 years; 97 [60%] male; 90 [55%] PAF; CHA2DS2-VASc 2.7 ± 1.7). Ablation was performed with 92 (56%) pts taking an AAD, which was stopped at a median of 80 [36, 105] days post-PVI. We defined 4 distinct groups: (1) no AF in 90-day BP (n = 75 [46%]); (2) last AF within 30 days of PVI (n = 32 [20%]); (3) last AF within 60 days of PVI (n = 17 [10%]); and (4) last AF within 90 days of PVI (n = 40 [24%]). Following the 90-day BP, 81 (49%) pts had a recurrence of AF. Long-term freedom from recurrent AF was similar in pts who did and did not use an AAD, irrespective of BP duration (Figure).
Conclusion
Our data suggest that the optimal BP duration in AF patients undergoing CB PVI while taking an AAD is 30 days. An AF recurrence after 30 days is associated with a very high likelihood of recurrent AF during longer-term follow-up, irrespective of whether an AAD is being used or not. Abstract Figure.
Collapse
Affiliation(s)
- D Musat
- Valley Health System, Ridgewood, United States of America
| | - NS Milstein
- Valley Health System, Ridgewood, United States of America
| | - M Saberito
- Valley Health System, Ridgewood, United States of America
| | - A Bhatt
- Valley Health System, Ridgewood, United States of America
| | - M Habibi
- Valley Health System, Ridgewood, United States of America
| | - T Sichrovsky
- Valley Health System, Ridgewood, United States of America
| | - MW Preminger
- Valley Health System, Ridgewood, United States of America
| | - RE Shaw
- Valley Health System, Ridgewood, United States of America
| | - S Mittal
- Valley Health System, Ridgewood, United States of America
| |
Collapse
|
15
|
Musat D, Milstein NS, Saberito M, Bhatt A, Habibi M, Preminger MW, Sichrovsky T, Shaw R, Mittal S. Defining the blanking period duration after cryoballoon pulmonary vein isolation in patients taking an antiarrhythmic drug. Europace 2021. [DOI: 10.1093/europace/euab116.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Cryoballoon pulmonary vein isolation (CB) is an accepted method for ablation in patients with atrial fibrillation (AF). A three-month blanking period (BP) is commonly used in clinical trials and practice. However, the actual BP duration in patients (pts) on an antiarrhythmic drug (AAD) at time of ablation remains undefined.
Objective
To objectively define the BP duration in pts undergoing CB while taking an AAD.
Methods
We enrolled consecutive pts with AF who had CB PVI while on an AAD. All pts had an implantable loop recorder (ILR). We prospectively followed all pts and determined the time to last AF episode during the 90-day post-PVI BP. This was then correlated with likelihood of having an AF recurrence between 3-12 months post-PVI.
Results
The cohort included 92 pts (66 ± 10 years; 62 [67%] male; 33 [36%] PAF; CHA2DS2-VASc 2.6 ± 1.7). AADs used included dofetilide (42), dronedarone (14), amiodarone (25), sotalol and propafenone (3 each), and flecainide (5). The AAD was stopped at a median of 80 [36, 105] days post-PVI. We defined 4 distinct groups: (1) no AF in 90-day BP (n = 45 [49%]); (2) last AF within 30 days of PVI (n = 17 [18%]); (3) last AF within 60 days of PVI (n = 13 [15%]); and (4) last AF within 90 days of PVI (n = 17 [18%]). Following the 90-day BP, 47 (51%) pts had a recurrence of AF. Once recurrent AF was observed > 30 days post-ablation, patients had high likelihood of having a long term AF recurrence (p = 0.037, Figure).
Conclusion
Our data suggest that the optimal BP duration in AF patients undergoing CB PVI while taking an AAD is 30 days. An AF recurrence after 30 days is associated with a very high likelihood of recurrent AF during longer-term follow-up. Abstract Figure.
Collapse
Affiliation(s)
- D Musat
- Valley Health System, Ridgewood, United States of America
| | - NS Milstein
- Valley Health System, Ridgewood, United States of America
| | - M Saberito
- Valley Health System, Ridgewood, United States of America
| | - A Bhatt
- Valley Health System, Ridgewood, United States of America
| | - M Habibi
- Valley Health System, Ridgewood, United States of America
| | - MW Preminger
- Valley Health System, Ridgewood, United States of America
| | - T Sichrovsky
- Valley Health System, Ridgewood, United States of America
| | - R Shaw
- Valley Health System, Ridgewood, United States of America
| | - S Mittal
- Valley Health System, Ridgewood, United States of America
| |
Collapse
|
16
|
Kittner M, Lamping M, Rieke DT, Götze J, Bajwa B, Jelas I, Rüter G, Hautow H, Sänger M, Habibi M, Zettwitz M, de Bortoli T, Ostermann L, Ševa J, Starlinger J, Kohlbacher O, Malek NP, Keilholz U, Leser U. Annotation and initial evaluation of a large annotated German oncological corpus. JAMIA Open 2021; 4:ooab025. [PMID: 33898938 PMCID: PMC8054032 DOI: 10.1093/jamiaopen/ooab025] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Revised: 03/08/2021] [Accepted: 03/18/2021] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE We present the Berlin-Tübingen-Oncology corpus (BRONCO), a large and freely available corpus of shuffled sentences from German oncological discharge summaries annotated with diagnosis, treatments, medications, and further attributes including negation and speculation. The aim of BRONCO is to foster reproducible and openly available research on Information Extraction from German medical texts. MATERIALS AND METHODS BRONCO consists of 200 manually deidentified discharge summaries of cancer patients. Annotation followed a structured and quality-controlled process involving 2 groups of medical experts to ensure consistency, comprehensiveness, and high quality of annotations. We present results of several state-of-the-art techniques for different IE tasks as baselines for subsequent research. RESULTS The annotated corpus consists of 11 434 sentences and 89 942 tokens, annotated with 11 124 annotations for medical entities and 3118 annotations of related attributes. We publish 75% of the corpus as a set of shuffled sentences, and keep 25% as held-out data set for unbiased evaluation of future IE tools. On this held-out dataset, our baselines reach depending on the specific entity types F1-scores of 0.72-0.90 for named entity recognition, 0.10-0.68 for entity normalization, 0.55 for negation detection, and 0.33 for speculation detection. DISCUSSION Medical corpus annotation is a complex and time-consuming task. This makes sharing of such resources even more important. CONCLUSION To our knowledge, BRONCO is the first sizable and freely available German medical corpus. Our baseline results show that more research efforts are necessary to lift the quality of information extraction in German medical texts to the level already possible for English.
Collapse
Affiliation(s)
- Madeleine Kittner
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Mario Lamping
- Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Damian T Rieke
- Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Julian Götze
- Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany
| | - Bariya Bajwa
- Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany
| | - Ivan Jelas
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Gina Rüter
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Hanjo Hautow
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Mario Sänger
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Maryam Habibi
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Marit Zettwitz
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Till de Bortoli
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Leonie Ostermann
- Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany
| | - Jurica Ševa
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Johannes Starlinger
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| | - Oliver Kohlbacher
- Institut für Translationale Bioinformatik, Universitätsklinikum Tübingen, Tübingen, Germany
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany
- Department of Computer Science, University of Tübingen, Tübingen, Germany
- Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany
| | - Nisar P Malek
- Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany
| | - Ulrich Keilholz
- Charité Comprehensive Cancer Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Ulf Leser
- Knowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany
| |
Collapse
|
17
|
Habibi M, Manouchehri Ardekani R, Motedayyen H. Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all- trans retinoic acid and arsenic trioxide. Clin Case Rep 2021; 9:2192-2195. [PMID: 33936662 PMCID: PMC8077381 DOI: 10.1002/ccr3.3978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Revised: 01/15/2021] [Accepted: 02/11/2021] [Indexed: 11/30/2022] Open
Abstract
Thrombocytosis is an unusual side effect of all-trans retinoic acid (ATRA) treatment that occurs in some patients with acute promyelocytic leukemia (APL).
Collapse
Affiliation(s)
- Maryam Habibi
- Autoimmune Diseases Research CenterKashan University of Medical SciencesKashanIran
| | | | - Hossein Motedayyen
- Autoimmune Diseases Research CenterKashan University of Medical SciencesKashanIran
| |
Collapse
|
18
|
Bahrami M, Qanai F, Mirmohammadi J, Askarishahi M, Barkhordari A, Habibi M, Mehrparvar A. Estimation of the aerobic capacity by step test in the workers of a tile factory in Yazd in 2017. Occup Med (Lond) 2020. [DOI: 10.18502/tkj.v11i4.3650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Introduction: Estimation of the maximum aerobic capacity to find a physiological fitness between worker and the work is of great importance. The purpose of this study was to estimate the highest aerobic capacity and physical work capacity of tile and ceramic workers.
Materials and methods: In this cross-sectional study, 90 workers were randomly selected from tile and ceramic workers in Yazd. A questionnaire consisting of two parts was used as data collection tool. The first part of the questionnaire included demographic characteristics completed by the interview. In the second part, parameters including height, weight, BMI and heart rate were inserted in the questionnaire. The Queen step test was used to measure the maximum aerobic capacity. The data were analyzed by SPSS software using Mann-Whitney and Kruskal-Wallis tests and Spearman,s test.
Results: The maximum aerobic capacity in tile and ceramic workers was estimated to be 3.60±.0.03 L/m. The results showed that aerobic capacity was significantly correlated with weight and body mass index. Also, there was no significant relationship between aerobic capacity, smoking and exercise, and education, but there was a significant relationship between gob title and aerobic capacity.
Conclusion: Weight, BMI and type of occupation affect the aerobic capacity of workers.
Collapse
|
19
|
Abstract
The purpose of the present study is to examine the effect of information literacy skills instruction on the lifelong learning readiness of users in Iranian public libraries. To this end, 30 active users of two libraries were randomly placed in control and experimental groups. Information literacy skills were taught to the experimental group over one and a half months. The results revealed that information literacy instruction led to a significant increase in readiness for self-directed learning and readiness to overcome deterrents to participation. According to the findings, information literacy skills instruction made a significant difference to the information literacy of users in Iranian public libraries. The results of this study encourage public libraries to plan for the implementation of information literacy instruction in order to make public libraries lifelong learning centres.
Collapse
|
20
|
Seyfizadeh N, Saboori H, Borzoueisileh S, Habibi M, Elahimanesh F. ABO blood groups as a new potential predictive factor in radiotherapy hematological changes. ACTA ACUST UNITED AC 2020; 121:67-72. [PMID: 31950842 DOI: 10.4149/bll_2020_010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
AIM Cancer treatments specially with new high Tec radiotherapy equipment's calling daily progression in method and predictive factors affecting treatment goals. Due to important effect of oxygen on cells radio sensitivity, tumor blood circulation and it's antigens like ABO blood groups maybe an important predictive factor for radiotherapy response and it is adverse events. The aim of this study was the assessment of the hematological manifestations of local radiotherapy and association with ABO blood groups. METHODS In this observational study, 2 ml of peripheral blood were taken from 152 patients with routine 3D conformal radiotherapy treatment course and the blood parameters achieve and documented at four stage during treatment courses. The data were analyzed by repeated measurement andone-way ANOVA. RESULTS Statistically significant reductions of the platelets, white blood cells (WBC), and lymphocytes counts were demonstrated. Also an increased percentage of polymorphonuclear cells during local radiotherapy exposure was found. The changes in WBC counts were observed to be in association with ABO blood groups. The other evaluated factors were not significantly associated with ABO blood groups. CONCLUSIONS Our results showed an association between radiotherapy patients ABO blood groups and some hematological changes in their blood circulation (Fig. 7, Ref. 23).
Collapse
|
21
|
Ghobadi N, Hafezi F, Naderi S, Amiri F, Luna C, Arman A, Shakoury R, Ţălu Ş, Rezaee S, Habibi M, Mardani M. Microstructure and Optical Bandgap of Cobalt Selenide Nanofilms. Semiconductors 2019. [DOI: 10.1134/s1063782619130074] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
22
|
Soltani Z, Sohrabi M, Habibi M. Analysis of 3D deuterium ion emission angular distribution in plasma focus device using novel panorama polycarbonate detectors. Radiat Phys Chem Oxf Engl 1993 2019. [DOI: 10.1016/j.radphyschem.2019.108404] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
23
|
Goodarzi P, Akhlaghi A, Zamiri MJ, Shirazi MRJ, Akhlaghi AA, Habibi M, Daryabari H, Saemi F, Peebles ED. Sperm characteristics of Chukar partridge (Alectoris chukar) breeders as affected by the addition of calcitriol to the semen extender. Poult Sci 2019; 98:3292-3297. [PMID: 30944932 DOI: 10.3382/ps/pez158] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2018] [Accepted: 03/09/2019] [Indexed: 12/26/2022] Open
Abstract
This study was carried out to determine the effect of supplementing the semen extender with calcitriol on in vitro sperm characteristics in Chukar partridges. A total of 60 male Chukar partridges were habituated for semen collection by abdominal massage. Pooled ejaculates from several males were extended (1 to 5 v/v ratio) in the Sexton's diluent containing 0, 24, 48, 96, or 192 μg calcitriol/mL. These concentrations represented 0-, 2-, 4-, 8-, and 16-fold levels of the mean seminal calcitriol concentration, respectively. A total of 12 subsamples from each treatment group were kept at 4 to 5°C or 19 to 24°C for 4, 24, or 48 h. The percentages of motile sperm, live sperm, abnormal sperm, incidence of hypoosmotic swelling (HOS), and thiobarbituric acid reactive species (TBARS) concentrations were determined. The data were analyzed by the xtmixed procedure of STATA software. The percentages of motile sperm, live sperm, abnormal sperm, and seminal TBARS were affected by calcitriol (P < 0.05). There was no effect of treatments on HOS (P > 0.05). There was an interaction effect between calcitriol, storage time, and storage temperature on sperm motility, sperm viability, and seminal TBARS. Supplementation of the diluent with 96 μg calcitriol/mL resulted in the highest sperm motility at 4°C. Also, the same treatment group recorded the highest sperm viability and lowest seminal TBARS at 19 to 24°C. Supplementing the diluent with calcitriol had beneficial effects on spermatozoa; however, the fertility rate of spermatozoa extended in calcitriol-supplemented diluent needs to be determined before the procedure can be recommended for use in artificial insemination programs.
Collapse
Affiliation(s)
- P Goodarzi
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - A Akhlaghi
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - M J Zamiri
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - M R Jafarzadeh Shirazi
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - A A Akhlaghi
- Department of Epidemiology and Reproductive Health, Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran 16635-148, Iran
| | - M Habibi
- Department of Animal and Food Sciences, Oklahoma State University, Stillwater, OK 74078
| | - H Daryabari
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - F Saemi
- Department of Animal Science, School of Agriculture, Shiraz University, Shiraz 71441-65186, Iran
| | - E D Peebles
- Department of Poultry Science, Mississippi State University, MS 39762
| |
Collapse
|
24
|
Amorim A, Bauböck M, Berger JP, Brandner W, Clénet Y, Coudé du Foresto V, de Zeeuw PT, Dexter J, Duvert G, Ebert M, Eckart A, Eisenhauer F, Förster Schreiber NM, Garcia P, Gao F, Gendron E, Genzel R, Gillessen S, Habibi M, Haubois X, Henning T, Hippler S, Horrobin M, Hubert Z, Jiménez Rosales A, Jocou L, Kervella P, Lacour S, Lapeyrère V, Le Bouquin JB, Léna P, Ott T, Paumard T, Perraut K, Perrin G, Pfuhl O, Rabien S, Rodríguez-Coira G, Rousset G, Scheithauer S, Sternberg A, Straub O, Straubmeier C, Sturm E, Tacconi LJ, Vincent F, von Fellenberg S, Waisberg I, Widmann F, Wieprecht E, Wiezorrek E, Yazici S. Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black Hole. Phys Rev Lett 2019; 122:101102. [PMID: 30932663 DOI: 10.1103/physrevlett.122.101102] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Indexed: 06/09/2023]
Abstract
During its orbit around the four million solar mass black hole Sagittarius A* the star S2 experiences significant changes in gravitational potential. We use this change of potential to test one part of the Einstein equivalence principle: the local position invariance (LPI). We study the dependency of different atomic transitions on the gravitational potential to give an upper limit on violations of the LPI. This is done by separately measuring the redshift from hydrogen and helium absorption lines in the stellar spectrum during its closest approach to the black hole. For this measurement we use radial velocity data from 2015 to 2018 and combine it with the gravitational potential at the position of S2, which is calculated from the precisely known orbit of S2 around the black hole. This results in a limit on a violation of the LPI of |β_{He}-β_{H}|=(2.4±5.1)×10^{-2}. The variation in potential that we probe with this measurement is six magnitudes larger than possible for measurements on Earth, and a factor of 10 larger than in experiments using white dwarfs. We are therefore testing the LPI in a regime where it has not been tested before.
Collapse
Affiliation(s)
- A Amorim
- Universidade de Lisboa-Faculdade de Ciências, Campo Grande, 1749-016 Lisboa, Portugal
- CENTRA-Centro de Astrofísica e Gravitação, IST, Universidade de Lisboa, 1049-001 Lisboa, Portugal
| | - M Bauböck
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - J P Berger
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - W Brandner
- Max Planck Institute for Astronomy, Königstuhl 17, 69117 Heidelberg, Germany
| | - Y Clénet
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - V Coudé du Foresto
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - P T de Zeeuw
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
- Sterrewacht Leiden, Leiden University, Postbus 9513, 2300 RA Leiden, Netherlands
| | - J Dexter
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - G Duvert
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - M Ebert
- Max Planck Institute for Astronomy, Königstuhl 17, 69117 Heidelberg, Germany
| | - A Eckart
- 1st Institute of Physics, University of Cologne, Zülpicher Strae 77, 50937 Cologne, Germany
- Max Planck Institute for Radio Astronomy, Auf dem Hügel 69, 53121 Bonn, Germany
| | - F Eisenhauer
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - N M Förster Schreiber
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - P Garcia
- Faculdade de Engenharia, Universidade do Porto, rua Dr. Roberto Frias, 4200-465 Porto, Portugal
- European Southern Observatory, Casilla 19001, Santiago 19, Chile
- CENTRA-Centro de Astrofísica e Gravitação, IST, Universidade de Lisboa, 1049-001 Lisboa, Portugal
| | - F Gao
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - E Gendron
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - R Genzel
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
- Departments of Physics and Astronomy, Le Conte Hall, University of California, Berkeley, California 94720, USA
| | - S Gillessen
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - M Habibi
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - X Haubois
- European Southern Observatory, Casilla 19001, Santiago 19, Chile
| | - Th Henning
- Max Planck Institute for Astronomy, Königstuhl 17, 69117 Heidelberg, Germany
| | - S Hippler
- Max Planck Institute for Astronomy, Königstuhl 17, 69117 Heidelberg, Germany
| | - M Horrobin
- 1st Institute of Physics, University of Cologne, Zülpicher Strae 77, 50937 Cologne, Germany
| | - Z Hubert
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - A Jiménez Rosales
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - L Jocou
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - P Kervella
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - S Lacour
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - V Lapeyrère
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - J-B Le Bouquin
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - P Léna
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - T Ott
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - T Paumard
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - K Perraut
- Univ. Grenoble Alpes, CNRS, IPAG, 38000 Grenoble, France
| | - G Perrin
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - O Pfuhl
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - S Rabien
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - G Rodríguez-Coira
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - G Rousset
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - S Scheithauer
- Max Planck Institute for Astronomy, Königstuhl 17, 69117 Heidelberg, Germany
| | - A Sternberg
- School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
- Center for Computational Astrophysics, Flatiron Institute, 162 5th Ave., New York, New York 10010, USA
| | - O Straub
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - C Straubmeier
- 1st Institute of Physics, University of Cologne, Zülpicher Strae 77, 50937 Cologne, Germany
| | - E Sturm
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - L J Tacconi
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - F Vincent
- LESIA, Observatoire de Paris, Université PSL, CNRS, Sorbonne Université, University Paris Diderot, Sorbonne Paris Cité, 5 place Jules Janssen, 92195 Meudon, France
| | - S von Fellenberg
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - I Waisberg
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - F Widmann
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - E Wieprecht
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - E Wiezorrek
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
| | - S Yazici
- Max Planck Institute for extraterrestrial Physics, Giessenbachstrae 1, 85748 Garching, Germany
- 1st Institute of Physics, University of Cologne, Zülpicher Strae 77, 50937 Cologne, Germany
| |
Collapse
|
25
|
Hannah M, Prasath V, Habibi M. Utilizing business intelligence and lean system applications to improve efficiency in breast surgery by reducing case delays. Breast 2019. [DOI: 10.1016/s0960-9776(19)30446-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
26
|
Blumencranz P, Habibi M, Treece T, Blumencranz L, Yoder E, Audeh W, Carter E, McNaughton L, Roussos J, Shivers S, Acs G, Cox C, MINT Investigators G. Abstract PD8-04: Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd8-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Neoadjuvant chemotherapy (NAC) is employed in patients with larger tumors to attempt to downstage locally advanced cancers to allow breast conservation and to assess in vivo tumor response. The Multi-Institutional Neoadjuvant Therapy MammaPrint Project I (MINT) study asked a secondary question of whether complete nodal downstaging could also be achieved with NAC.
Methods: This analysis included 147 eligible invasive breast cancer patients with high tumor burdens, classified as cT2-4N0-3M0 (T2 greater than 3.5cm if N0). Patients who had a positive core biopsy and/or fine needle aspiration (FNA) on an axillary node prior to starting NAC were included in this analysis. Those who had a surgical sentinel lymph node biopsy were not included. Nodal involvement was established following neoadjuvant treatment by axillary lymph node dissection (ALND).
Results: This population was 54% postmenopausal, average age 53 yrs (range 25 to 80 yrs). Tumor characteristics were 91% invasive ductal carcinoma; 65% T2, 29% T3, 6% T4; 87% LN1, 13% LN2-3; 3% low grade, 38% intermediate grade, 59% high grade; 65% ER-positive, 49% PR-positive, and 28% HER2-positive by immunohistochemistry; 84% High Risk (HR) and 16% Low Risk (LR) by MammaPrint (MP). After NAC, 45% (66/147) of these LN-positive patients were down-staged to ypN0 and also achieved a complete pathological response in the primary tumor. The potential for down-staging was inversely-related to tumor burden, where 47% (60/128) of N1, 35% (6/17) of N2, and 0% (0/2) of N3 patients were down-staged to ypN0. There were 3 patients who were down-staged (2 N2 to N1, and 1 N3 to N2), but not to ypN0. At surgery, 34% (44/128) of patients had no change, and 19% (24/129) progressed in LN staging.
Pre vs Post NAC Nodal StagePre NAC Nodal StageypN0ypN1ypN2ypN3TotalcN16044222128cN2626317cN3 112Total6646296147
Conclusions: We confirmed that upon achieving a complete response of the primary tumor that there was also a pathologic complete response in the LN. About 53% of patients had no change or progression of LN involvement following NAC.
Citation Format: Blumencranz P, Habibi M, Treece T, Blumencranz L, Yoder E, Audeh W, Carter E, McNaughton L, Roussos J, Shivers S, Acs G, Cox C, MINT Investigators Group. Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD8-04.
Collapse
Affiliation(s)
- P Blumencranz
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - M Habibi
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - T Treece
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - L Blumencranz
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - E Yoder
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - W Audeh
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - E Carter
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - L McNaughton
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - J Roussos
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - S Shivers
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - G Acs
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - C Cox
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| | - Group MINT Investigators
- Morton Plant Hospital, Clearwater, FL; Johns Hopkins Breast Center at Bayview, Baltimore, MD; Agendia, Inc, Irvine, CA; University of South Florida, Tampa, FL; Florida Hospital Tampa, Tampa, FL
| |
Collapse
|
27
|
Blumencranz LE, Høst-Ragab A, Retèl VP, Garlich H, Hwang C, Neijenhuis S, Habibi M, Audeh W. Abstract P5-15-08: Economic Impact of MammaPrint (70-gene signature) in a clinical high risk population: A 10yr Markov model, 6,000-patient retrospective analysis of US claim data. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-15-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: MINDACT provided evidence that MammaPrint (MP) can identify patients (pts) with early-stage breast cancer (ESBC) who can safely forego adjuvant chemotherapy (CT). As a result, 46% of clinicopathologically high-risk pts were spared from unnecessary CT toxicities. This study investigates direct and indirect costs for pts and payers during ESBC treatment regimens. The study objective was to quantify average cost of care and savings in a clinical high-risk group where the value of CT is unclear, and MP demonstrates economic and clinical impact. Methods: Risk assessment was based on 6,000 MP tests performed on BCBS members (2016-17). CT claims were retrospectively analyzed utilizing a Blue Cross Blue Shield (BCBS) member database (January-December 2016). Case data was restricted to HR+HER2- ESBC and filtered by authorization for the MP test. All CT claims were including, but not limited to standard of care (SOC) systemic drugs such as cyclophosphamide, docetaxel, paclitaxel and doxorubicin. HCPCS codes were utilized to filter member CT claims. Exclusion criteria: <3 SOC CT claims and previous history of BC. A hybrid decision tree-Markov model was used to estimate cost effectiveness of MP compared to modified Adjuvant Online (mAOL) from a US healthcare payer perspective over a 10yr timeframe. Overall, distant metastasis free survival, and test-utility scores were collected from MINDACT for HR+HER2- pts, and costs derived from the BCBS registry and literature (2016 US dollars). Two scenarios were modelled (1) all women classified as high-risk received CT plus endocrine therapy (ET) while low-risk pts received ET; (2) MP guided treatment was modelled based on the IMPACT study (91% MP Low Risk pts received ET and 83% MP High Risk pts received CT). Outcome measures were quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs). Results: The majority, 3,540 (59.0%) pts were Low Risk or could safely forgo CT; 2,460 (41.0%) were High Risk. The primary driver for cost differences was whether all services were performed in a physician office ($4.6M) or an outpatient setting ($2M). Including provider settings (inpatient, outpatient, emergency), SOC CT regimens and related services the final average amount authorized was $39,675 per patient. In the first scenario, MP guided treatment was associated with a 0.06 QALY gain (0.05 in scenario 2) compared to mAOL. For cost savings and QALY gain MP was dominant over mAOL in both scenarios. Budget impact analysis estimated cost savings of 88.2- 96.6 million dollars based on BCBS registry data. Given the new cases of BC that are expected to be diagnosed in women in the U.S. annually, pts covered in this population by BCBS (˜30%) and MP eligible cohort (˜36K pts), projected cost savings are estimated at 529.2-644.3 million dollars per annum for the health insurer. Conclusions: CT was associated with significant annual costs from both patient and payer perspectives. As demonstrated in MINDACT, less treatment for some pts is optimal without risk to safety or survival. These findings suggest that MP is cost effective and provides substantial value by sparing pts from toxicities, both therapeutic and financial.
Citation Format: Blumencranz LE, Høst-Ragab A, Retèl VP, Garlich H, Hwang C, Neijenhuis S, Habibi M, Audeh W. Economic Impact of MammaPrint (70-gene signature) in a clinical high risk population: A 10yr Markov model, 6,000-patient retrospective analysis of US claim data [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-15-08.
Collapse
Affiliation(s)
- LE Blumencranz
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - A Høst-Ragab
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - VP Retèl
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - H Garlich
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - C Hwang
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - S Neijenhuis
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - M Habibi
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| | - W Audeh
- Agendia Inc, Irvine, CA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; BlueCross Blue Shield California, Rancho Cordova, CA; Blue Cross Blue Shield, San Francisco, CA; Johns Hopkins Breast Center at Bayview, Baltimore, MD
| |
Collapse
|
28
|
Affiliation(s)
- M. Habibi
- Department of Statistics, University of Mazandaran, Babolsar, Iran
| | - A. Asgharzadeh
- Department of Statistics, University of Mazandaran, Babolsar, Iran
| |
Collapse
|
29
|
Abbasi F, Habibi M, Enayati S, Bitarafan F, Razzaghy-Azar M, Sotodeh A, Omran SP, Maroofian R, Amoli MM. A Genotype-First Approach for Clinical and Genetic Evaluation of Wolcott-Rallison Syndrome in a Large Cohort of Iranian Children With Neonatal Diabetes. Can J Diabetes 2018; 42:272-275. [DOI: 10.1016/j.jcjd.2017.06.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2017] [Revised: 06/12/2017] [Accepted: 06/21/2017] [Indexed: 11/15/2022]
|
30
|
Kavehei B, Habibi M, Sari S, Asadi Karam MR. Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis. vacres 2018. [DOI: 10.29252/vacres.5.1.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
|
31
|
Afsharmanesh M, Habibi M. Development of a helicon ion source: Simulations and preliminary experiments. Rev Sci Instrum 2018; 89:033301. [PMID: 29604751 DOI: 10.1063/1.5010010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
In the present context, the extraction system of a helicon ion source has been simulated and constructed. Results of the ion source commissioning at up to 20 kV are presented as well as simulations of an ion beam extraction system. Argon current of more than 200 μA at up to 20 kV is extracted and is characterized with a Faraday cup and beam profile monitoring grid. By changing different ion source parameters such as RF power, extraction voltage, and working pressure, an ion beam with current distribution exhibiting a central core has been detected. Jump transition of ion beam current emerges at the RF power near to 700 W, which reveals that the helicon mode excitation has reached this power. Furthermore, measuring the emission line intensity of Ar ii at 434.8 nm is the other way we have used for demonstrating the mode transition from inductively coupled plasma to helicon. Due to asymmetrical longitudinal power absorption of a half-helix helicon antenna, it is used for the ion source development. The modeling of the plasma part of the ion source has been carried out using a code, HELIC. Simulations are carried out by taking into account a Gaussian radial plasma density profile and for plasma densities in range of 1018-1019 m-3. Power absorption spectrum and the excited helicon mode number are obtained. Longitudinal RF power absorption for two different antenna positions is compared. Our results indicate that positioning the antenna near to the plasma electrode is desirable for the ion beam extraction. The simulation of the extraction system was performed with the ion optical code IBSimu, making it the first helicon ion source extraction designed with the code. Ion beam emittance and Twiss parameters of the ellipse emittance are calculated at different iterations and mesh sizes, and the best values of the mesh size and iteration number have been obtained for the calculations. The simulated ion beam extraction system has been evaluated using optimized parameters such as the gap distance between electrodes, electrodes aperture, and extraction voltage. The gap distance, ground electrode aperture, and extraction voltage have been changed between 3 and 9 mm, 2-6.5 mm, and 10-35 kV in the simulations, respectively.
Collapse
Affiliation(s)
- M Afsharmanesh
- Department of Energy Engineering and Physics, Amirkabir University of Technology, Tehran, Iran
| | - M Habibi
- Department of Energy Engineering and Physics, Amirkabir University of Technology, Tehran, Iran
| |
Collapse
|
32
|
Hosseini S, Jashni E, Habibi M, Nemati M, Van der Bruggen B. Evaluating the ion transport characteristics of novel graphene oxide nanoplates entrapped mixed matrix cation exchange membranes in water deionization. J Memb Sci 2017. [DOI: 10.1016/j.memsci.2017.07.022] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Mirzaali MJ, Habibi M, Janbaz S, Vergani L, Zadpoor AA. Crumpling-based soft metamaterials: the effects of sheet pore size and porosity. Sci Rep 2017; 7:13028. [PMID: 29026106 PMCID: PMC5638806 DOI: 10.1038/s41598-017-12821-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2017] [Accepted: 09/15/2017] [Indexed: 11/09/2022] Open
Abstract
Crumpled-based materials are relatively easy to fabricate and show robust mechanical properties for practical applications, including meta-biomaterials design aimed for improved tissue regeneration. For such requests, however, the structure needs to be porous. We introduce a crumpled holey thin sheet as a robust bio-metamaterial and measure the mechanical response of a crumpled holey thin Mylar sheet as a function of the hole size and hole area fraction. We also study the formation of patterns of crease lines and ridges. The area fraction largely dominated the crumpling mechanism. We also show, the crumpling exponents slightly increases with increasing the hole area fraction and the total perimeter of the holes. Finally, hole edges were found to limit and guide the propagation of crease lines and ridges.
Collapse
Affiliation(s)
- M J Mirzaali
- Department of Mechanical Engineering, Politecnico di Milano, Via La Masa 1, 20156, Milano, Italy. .,Department of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology (TU Delft), Mekelweg 2, 2628 CD, Delft, The Netherlands.
| | - M Habibi
- Physics and Physical Chemistry of Foods, Department of Agrotechnology and Food Sciences, Wageningen University, Wageningen, The Netherlands
| | - S Janbaz
- Department of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology (TU Delft), Mekelweg 2, 2628 CD, Delft, The Netherlands
| | - L Vergani
- Department of Mechanical Engineering, Politecnico di Milano, Via La Masa 1, 20156, Milano, Italy
| | - A A Zadpoor
- Department of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology (TU Delft), Mekelweg 2, 2628 CD, Delft, The Netherlands
| |
Collapse
|
34
|
Habibi M, Karimi V, Langeroudi AG, Ghafouri SA, Hashemzadeh M, Farahani RK, Maghsoudloo H, Abdollahi H, Seifouri P. Combination of H120 and 1/96 avian infectious bronchitis virus vaccine strains protect chickens against challenge with IS/1494/06 (variant 2)-like infectious bronchitis virus. Acta Virol 2017; 61:150-160. [PMID: 28523921 DOI: 10.4149/av_2017_02_04] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Avian infectious bronchitis (IB) is a worldwide chicken disease, caused by avian infectious bronchitis virus (IBV) which infects all commercial poultry lines. The present study was done to evaluate protection caused by two different serotype vaccines (Massachusetts and 793/B) in order to evaluate protection against challenge with IS/1494/06-like virus (variant 2-like virus), which is prevalent in the Middle East. SPF chickens were divided into four groups (n = 20). First and second group as negative control group and non-vaccinated-challenged group received no vaccine. Groups 3 and 4 received H120-H120 and H120-1/96 IBV vaccine strains at the 1st and 14th day, respectively. Twenty one days after last vaccination, non-vaccinated-challenged group and vaccinated group were challenged using variant 2-like IBV. Serum samples were collected before challenge to measure humoral immune response of chickens. Five days after challenge, the tissue samples from the trachea, lungs and kidneys were taken to evaluate cilliary activity, viral load (quantitative real-time RT-PCR), and histopathological evaluation. Clinical sign scores were also recorded after challenge. Overall, the results showed a protective efficacy of the used vaccination program. Best cross protection (69.2%) was obtained in the H120-1/96 vaccinated group. Virus replication of the challenged virus in H120-1/96 group compared with H120-H120 group showed a significant reduction of viral load in trachea (1.5×103 compared to 503) and kidneys. Clinical sign scores of the challenged groups showed significant effect of the vaccination program to reduce clinical signs. The trachea pathological scores and histopathological findings in the lungs and kidneys also confirmed better protective efficacy of vaccinated groups. In conclusion, using combination of heterologous IBV vaccine serotypes (Massachusetts and 793/B) would be a better strategy to control variant 2-like viruses, but more evaluation is needed using other circulating isolates to find the best combination of vaccines.
Collapse
|
35
|
Abstract
MOTIVATION Text mining has become an important tool for biomedical research. The most fundamental text-mining task is the recognition of biomedical named entities (NER), such as genes, chemicals and diseases. Current NER methods rely on pre-defined features which try to capture the specific surface properties of entity types, properties of the typical local context, background knowledge, and linguistic information. State-of-the-art tools are entity-specific, as dictionaries and empirically optimal feature sets differ between entity types, which makes their development costly. Furthermore, features are often optimized for a specific gold standard corpus, which makes extrapolation of quality measures difficult. RESULTS We show that a completely generic method based on deep learning and statistical word embeddings [called long short-term memory network-conditional random field (LSTM-CRF)] outperforms state-of-the-art entity-specific NER tools, and often by a large margin. To this end, we compared the performance of LSTM-CRF on 33 data sets covering five different entity classes with that of best-of-class NER tools and an entity-agnostic CRF implementation. On average, F1-score of LSTM-CRF is 5% above that of the baselines, mostly due to a sharp increase in recall. AVAILABILITY AND IMPLEMENTATION The source code for LSTM-CRF is available at https://github.com/glample/tagger and the links to the corpora are available at https://corposaurus.github.io/corpora/ . CONTACT habibima@informatik.hu-berlin.de.
Collapse
Affiliation(s)
- Maryam Habibi
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Leon Weber
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Mariana Neves
- Enterprise Platform and Integration Concepts, Hasso-Plattner-Institute, Potsdam, Germany
| | - David Luis Wiegandt
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Ulf Leser
- Computer Science Department, Humboldt-Universität zu Berlin, Berlin, Germany
| |
Collapse
|
36
|
Sarshar S, Brandt S, Asadi Karam MR, Habibi M, Bouzari S, Lechtenberg M, Dobrindt U, Qin X, Goycoolea FM, Hensel A. Aqueous extract from Orthosiphon stamineus leaves prevents bladder and kidney infection in mice. Phytomedicine 2017; 28:1-9. [PMID: 28478807 DOI: 10.1016/j.phymed.2017.02.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Revised: 12/08/2016] [Accepted: 02/27/2017] [Indexed: 06/07/2023]
Abstract
BACKGROUND Extracts from the leaves of Orthosiphon stamineus are used in phytotherapy for treatment of uncomplicated urinary tract infections. PURPOSES Evaluation of an aqueous extract against infection with uropathogenic Escherichia coli in vivo; investigation of underlying microbiological mechanisms. STUDY DESIGN In vivo studies in mice and in vitro investigations on cytotoxicity, antiadhesive potential, influence on bacterial gene expression and quorum sensing. METHODS Extract OWE was prepared by hot water extraction. For in vivo studies BALB/c mice were used in an UPEC infection model. The effect of OWE on bacterial load in bladder/kidney tissue was monitored in pre- and posttreatment. Cytotoxicity of OWE against different UPEC strains, T24 bladder/A498 kidney cells, gene expression analysis, monitoring of phenotypic motility and quorum sensing was investigated by standard methods of microbiology. RESULTS OWE was quantified (UHPLC) according to the content of rosmarinic acid, cichoric acid, caffeic acid. Three- and 5-day treatment of animals with OWE (750mg/kg) after transurethral infection with UPEC CFT073 reduced the bacterial load in bladder and kidney, similar to norfloxacin. Four- and 7-day pretreatment of mice prior to the infection with UPEC NU14 reduced bacterial bladder colonization. In vitro investigations indicated that OWE (≤2mg/ml) has no cytotoxic or proliferation-inhibiting activity against different UPEC strains as well as against T24 bladder and A498 kidney cells. OWE exerts a dose dependent antiadhesive activity against UPEC strains NU14 and UTI89. OWE reduced gene expression of fimH, but evoked increase of the expression of motility/fitness gene fliC. Increase of bacterial motility on gene level was confirmed by a changed bacterial phenotype by an increased bacterial motility in soft agar assay. OWE inhibited in a concentration-dependent manner bacterial quorum sensing. CONCLUSION OWE is assessed as a strong antiadhesive plant extract for which the traditional use in phytotherapy for UTI might be justified.
Collapse
Affiliation(s)
- S Sarshar
- University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Corrensstrasse 48, D-48149 Münster, Germany
| | - S Brandt
- University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Corrensstrasse 48, D-48149 Münster, Germany
| | - M R Asadi Karam
- Department of Molecular Biology, Pasteur Institute of Iran, Pasteur Avenue, Teheran 13164, Iran
| | - M Habibi
- Department of Molecular Biology, Pasteur Institute of Iran, Pasteur Avenue, Teheran 13164, Iran
| | - S Bouzari
- Department of Molecular Biology, Pasteur Institute of Iran, Pasteur Avenue, Teheran 13164, Iran
| | - M Lechtenberg
- University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Corrensstrasse 48, D-48149 Münster, Germany
| | - U Dobrindt
- University Hospital Münster, Institute of Hygiene, Mendelstraße 7, D-48149 Münster, Germany
| | - X Qin
- University of Münster, Institute of Biology and Plant Biotechnology, Schlossgarten 3, D-48149 Münster, Germany
| | - F M Goycoolea
- University of Münster, Institute of Biology and Plant Biotechnology, Schlossgarten 3, D-48149 Münster, Germany
| | - A Hensel
- University of Münster, Institute of Pharmaceutical Biology and Phytochemistry, Corrensstrasse 48, D-48149 Münster, Germany.
| |
Collapse
|
37
|
Dogan B, Dogan U, Erol MK, Habibi M, Oruc MT. Comparison of anterior segment parameter values obtained with Scheimpflug-Placido topographer, optical low coherence reflectometry and noncontact specular microscopy in morbid obesity. Eur Rev Med Pharmacol Sci 2017; 21:438-445. [PMID: 28239829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE To investigate the measurement of anterior segment parameters using Sirius Scheimpflug-Placido topographer, Lenstar optical low coherence reflectometry (OLCR), and noncontact specular microscopy (SM) in morbidly obese and nonobese subjects. PATIENTS AND METHODS Twenty-eight morbidly obese subjects (BMI ≥ 40; Group 1) and 28 age- sex-matched healthy nonobese subjects (BMI 18.50-24.99; Group 2) were included in this study. Anterior segment parameters were measured by Scheimpflug-Placido topographer and OLCR. Corneal endothelial cell parameters were measured by non-contact SM. The group data were analyzed using the Mann-Whitney U test and Student's t-test. Bland-Altman plots were used to assess agreement among the instruments, and 95% limits of agreement (LoA) for each comparison were calculated. RESULTS In group 1, the mean CCT by Scheimpflug-Placido topographer, OLCR, and noncontact SM were 549.44±30.10 µm, 544.15±31.48 µm, and 541.59±29.87 µm respectively. In group 2, the mean CCT by Scheimpflug-Placido topographer, OLCR, and noncontact SM were 531.0±22.09 µm, 523.15±21.39 µm, and 521.12±21.70 µm respectively. Mean CCT values obtained by the three methods were significantly higher in the morbidly obese than the nonobese subjects. In both groups, mean CCT was significantly higher when measured by Scheimpflug-Placido topographer than by OLCR and noncontact SM, and mean AD and ACD were significantly higher when measured by Scheimpflug-Placido topographer than OLCR. No significant differences were found between mean corneal curvature and corneal astigmatism when measured by Scheimpflug-Placido topographer and OLCR. CONCLUSIONS The mean CCT of the morbidly obese subjects were significantly higher than the nonobese subjects when measured by all three methods. The CCT values obtained by Scheimpflug-Placido topographer were significantly higher than those by OLCR and SM.
Collapse
Affiliation(s)
- B Dogan
- Department of Ophthalmology, Department of General Surgery; Antalya Training and Research Hospital, Antalya, Turkey.
| | | | | | | | | |
Collapse
|
38
|
Habibi M, Zamiri MJ, Akhlaghi A, Shahverdi AH, Alizadeh AR, Jaafarzadeh MR. Effect of dietary fish oil with or without vitamin E supplementation on fresh and cryopreserved ovine sperm. Anim Prod Sci 2017. [DOI: 10.1071/an15358] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
This study was carried out to determine whether dietary fish oil (FO) with or without vitamin E (VE) supplementation would have a beneficial effect on characteristics of fresh and cryopreserved ovine sperm. Sixteen rams were allotted to four groups and fed one of the four diets: control diet (CON; without FO and VE supplementation), VE diet supplying 200 IU VE/day.ram, FO diet containing 2.5% (dry matter basis) FO, and OVE diet containing FO and VE. Semen samples were collected at Weeks 7, 9 and 11 for evaluation of seminal quality. Frozen samples from Weeks 9 and 11 were subjected to computer-assisted semen analysis (CASA). Seminal volume, percentage of sperm with normal morphology and intact acrosome and seminal concentration of malondialdehyde were increased in FO rams (P < 0.05). In VE rams, semen volume and percentage of morphologically normal sperm were higher compared with CON rams; however, in OVE rams these attributes were not different from those in CON rams. Other traits in fresh semen were not affected by the diet. Fish oil alone negatively affected the sperm viability, but not motility, of the frozen–thawed semen; however, simultaneous supplementation with FO and VE resulted in increased percentage of morphologically normal sperm, motility, and viability. The percentages of CASA type A (showing rapid progressive motility) and type B (showing medium progressive motility) sperm were higher in OVE compared with other groups. Vitamin E supplementation decreased the beat-cross frequency values compared with other groups. Other CASA parameters were not affected by the diets. In conclusion, dietary FO and VE in the breeding season of ram, generally, do not cause significant changes in fresh sperm quality but, for cryopreservation of sperm, supplementation of the diet with an antioxidant such as VE may be beneficial when polyunsaturated fatty acids are added to the diet.
Collapse
|
39
|
Dogan U, Bulbuller N, Cakır T, Habibi M, Mayir B, Koc U, Aslaner A, Ellidag HY, Gomceli I. Nesfatin-1 hormone levels in morbidly obese patients after laparoscopic sleeve gastrectomy. Eur Rev Med Pharmacol Sci 2016; 20:1023-31. [PMID: 27049252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
OBJECTIVE To investigate changes in body mass index (BMI) and nesfatin-1 levels in patients with morbid obesity who had undergone laparoscopic sleeve gastrectomy (LSG). PATIENTS AND METHODS Blood samples were collected from, and the BMI calculated of 30 morbidly obese patients pre-surgery and at 3 and 6 months post-surgery. Nesfatin-1 hormone levels were measured using enzyme-linked immunosorbent assay (ELISA). Descriptive statistical analysis of the data was performed using Kruskal-Wallis variance analysis, one-way ANOVA, and the Bonferroni-Dunn test. The correlations between continuous variables not displaying normal distribution and those displaying normal distributions were analyzed using the Spearman correlation test and the Pearson correlation test, respectively. RESULTS The mean age of the 30 patients was 41.23 ± 10.37 years. The mean BMI values (kg/m2) were 49.30 ± 7.92, 39,48 ± 7.32, and 34.39 ± 7.56 presurgery, three months post-surgery, and six months post-surgery, respectively (p < 0.001). Mean nesfatin-1 levels (ng/ml) were 22.80 ± 14.16, 60.23 ± 52.92, and 96.99 ± 40.20 presurgery, three months post-surgery, and six months post-surgery, respectively (p < 0.001). The postoperative months 3 and 6 BMI values were significantly lower than the preoperative BMI value and the postoperative month 6 BMI value was significantly lower than the postoperative month 3 BMI value (p < 0.001). The postoperative months 3 and 6 nesfatin-1 levels were significantly higher than the preoperative nesfatin-1 levels. A negative correlation was found between age and preoperative nesfatin-1 values (p = 0.001, r = -0.0557). CONCLUSIONS Observation of significant increases in nesfatin-1 hormone levels in morbidly obese patients who had undergone LSG indicate that nesfatin-1 has important anorexigenic effects post-surgery and may be an important component of future obesity treatments.
Collapse
Affiliation(s)
- U Dogan
- General Surgery Department, Antalya Training and Research Hospital, Antalya, Turkey.
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Affiliation(s)
- A. Asgharzadeh
- Department of Statistics, University of Mazandaran, Babolsar, Iran
| | - Hassan S. Bakouch
- Department of Mathematics, Faculty of Science, Tanta University, Tanta, Egypt
| | - M. Habibi
- Department of Statistics, University of Mazandaran, Babolsar, Iran
| |
Collapse
|
41
|
Habibi M, Mahdabi P, Popescu-Belis A. Question answering in conversations: Query refinement using contextual and semantic information. DATA KNOWL ENG 2016. [DOI: 10.1016/j.datak.2016.06.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
42
|
Abstract
Recently, methods for Chemical Named Entity Recognition (NER) have gained substantial interest, driven by the need for automatically analyzing todays ever growing collections of biomedical text. Chemical NER for patents is particularly essential due to the high economic importance of pharmaceutical findings. However, NER on patents has essentially been neglected by the research community for long, mostly because of the lack of enough annotated corpora. A recent international competition specifically targeted this task, but evaluated tools only on gold standard patent abstracts instead of full patents; furthermore, results from such competitions are often difficult to extrapolate to real-life settings due to the relatively high homogeneity of training and test data. Here, we evaluate the two state-of-the-art chemical NER tools, tmChem and ChemSpot, on four different annotated patent corpora, two of which consist of full texts. We study the overall performance of the tools, compare their results at the instance level, report on high-recall and high-precision ensembles, and perform cross-corpus and intra-corpus evaluations. Our findings indicate that full patents are considerably harder to analyze than patent abstracts and clearly confirm the common wisdom that using the same text genre (patent vs. scientific) and text type (abstract vs. full text) for training and testing is a pre-requisite for achieving high quality text mining results.
Collapse
Affiliation(s)
- Maryam Habibi
- Knowledge Management in Bioinformatics, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| | - David Luis Wiegandt
- Knowledge Management in Bioinformatics, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| | | | - Ulf Leser
- Knowledge Management in Bioinformatics, Humboldt-Universität zu Berlin, 12489 Berlin, Germany
| |
Collapse
|
43
|
Shen C, Kummerlowe M, Morris C, Meyer C, Habibi M, Frassica D, Levin A, Thornton K, Terezakis S. Combined Modality Therapy Results in Improved Overall Survival for Angiosarcoma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
44
|
Parekh A, Asrari F, Camp M, Habibi M, Zellars R, Wright J. Trends in Axillary Management of Breast Cancer in Patients With Positive Sentinel Lymph Node. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Parekh A, Rao A, Asrari F, Camp M, Habibi M, Wright J. Hypofractionated Whole-Breast Radiation in Patients With High Body Mass Index. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
46
|
Habibi M, Kollaros N, Karyofyllis P, Mastorakou I, Voudris V. Factors affecting exposure parameters during diagnostic coronary catheterization. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.07.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
47
|
Kazemi M, Habibi M, Amrollahi R. Determination of Average Ion Temperature of the TVD Tokamak by a Simple Charge Exchange Analyzer Detector. J Fusion Energ 2016. [DOI: 10.1007/s10894-016-0102-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
48
|
Nematy M, Tashakori-Behesti A, Megarbane B, Bakaiyan M, Habibi M, Afashari R. Does diazinon-sprayed market melon alter cholinesterase activity in healthy consumers? A randomized control trial. Eur Rev Med Pharmacol Sci 2016; 20:2607-2612. [PMID: 27383312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Food contributes in measurable body burden of the widely used organophosphate pesticides. We designed a randomized controlled open label trial in Mashhad University Hospital in Iran, to study the possible alterations in cholinesterase activity resulting from consuming market melon known to be exposed to diazinon. PATIENTS AND METHODS Fifty-three young healthy volunteers were recruited. Participants were randomized to consume 250 g per day of organic (N = 22) vs. market melon (N = 31) during fifteen days. The primary outcome was the variation of red blood-cell (RBC) cholinesterase activity between day 15 (after) and day 0 (prior the intervention). The secondary outcome was a variation of the plasma cholinesterase activity between both dates. RESULTS Baseline RBC [5.21 ± 0.93 vs. 5.53 ± 0.99 IU/mL, mean ± SD] and plasma cholinesterase activities [54.0 ± 8.1 vs. 57.4 ± 8.6%] did not significantly differ between organic and market melon-exposed participants, respectively. RBC [5.86 ± 1.27 vs. 5.11 ± 1.2 IU/mL] and plasma cholinesterase activities [58.7 ± 10.0 vs. 50.5 ± 13.0%] significantly increased in organic melon-exposed vs. market melon-exposed participants (p = 0.002 and p = 0.001, respectively). CONCLUSIONS RBC and plasma cholinesterase activities significantly improved after eating organic instead of market melon during fifteen days. However, the consequences on the health of the observed cholinesterase alterations attributed to diazinon dietary intake remain to be determined.
Collapse
Affiliation(s)
- M Nematy
- Nutrition Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.
| | | | | | | | | | | |
Collapse
|
49
|
Dogan B, Kazim Erol M, Dogan U, Habibi M, Bulbuller N, Turgut Coban D, Bulut M. The retinal nerve fiber layer, choroidal thickness, and central macular thickness in morbid obesity: an evaluation using spectral-domain optical coherence tomography. Eur Rev Med Pharmacol Sci 2016; 20:886-891. [PMID: 27010146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE To assess the effect of morbid obesity on retinal nerve fiber layer (RNFL) thickness, central macular thickness (CMT), retinal ganglion cell (RGC), choroidal thickness (CT), central corneal thickness (CCT), and intraocular pressure (IOP). PATIENTS AND METHODS Sixty-seven patients defined as having morbid or class III obesity (BMI ≥ 40; Group 1) scheduled to undergo sleeve gastrectomy surgery and 29 nonobese patients (BMI 18.50-24.99; Group 2) underwent complete ophthalmic examination for measurement of IOP, CT, RNFL thickness, CMT, RGC, and CCT. RNFL thickness, CMT, and RGC were measured using spectral-domain optical coherence tomography (SD-OCT). CT measurement was performed using the enhanced depth imaging technique of the SD-OCT. The group data were analyzed and compared using the Mann-Whitney U test and Student's t-test. The relationship between the clinical ocular variables and obesity was analyzed using the Spearman's rank correlation test. RESULTS The mean IOP and CCT of Group 1 were found to be significantly higher (p < 0.001) and the mean RNFL, RGC, and CT significantly lower (p < 0.05) than those of Group 2. While Group 2 was found to have a slightly larger cup-to-disc ratio and Group 1 to have a thinner CMT, the differences between Groups 1 and 2 regarding these variables were not found to be statistically significant (p = 0.322 and p = 0.072, respectively). The results of Spearmen correlation analysis indicated the existence of a moderately positive correlation between IOP and BMI (p < 0.001; r = 0.5-0.6). CONCLUSIONS We have demonstrated by SD-OCT that morbid obesity may have a significant influence on RNFL, RGC, and CT. Morbid obesity may induce inflammatory, hormonal, and metabolic changes.
Collapse
Affiliation(s)
- B Dogan
- Department of Ophthalmology, Antalya Training and Research Hospital, Antalya, Turkey.
| | | | | | | | | | | | | |
Collapse
|
50
|
Choubini E, Asadi Karam MR, Khorshidi A, Habibi M, Ghasemi A, Bouzari S. Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection. vacres 2016. [DOI: 10.18869/acadpub.vacres.3.7.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|